Tom Cirrito, Ph.D., CEO of Varro Bio, was pleased to speak at Devcon 2024, taking place in Bangkok, Thailand. His presentation, titled Next-Generation Platform to Prevent the Spread of Infectious Disease, can be viewed below: https://www.youtube.com/watch?v=fHaE0iv9Szs About Devcon: Devcon is…
Recall how long it took, in the depths of the COVID-19 pandemic, to screen yourself with the gold-standard method, the PCR test: You’d swab your nostrils, hand the swab to the person at the pharmacy or clinic, then wait while…
Varro Receives $20 Million from Vitalik Buterin to Support Development of Cutting-Edge Pathogen Biosensor Technology Varro to enable improved pathogen detection worldwide by making its proprietary biosensor tech platform available via Open Source NEW YORK, ST. LOUIS and SINGAPORE -…
Technology developed by Washington University in St. Louis that detects SARS-CoV-2 and other viral, bacterial, and fungal pathogens in people and spaces in under 60 seconds Addressing new threats: In the event a new pathogenic threat emerges, Varro can create…
Scientists at Washington University in St. Louis have developed a breath test that quickly identifies those who are infected with the virus that causes COVID-19. The device requires only one or two breaths and provides results in less than a…
The scientific journal ACS Sensors published a report by Varro Life Science’s academic collaborators entitled “Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.” The research notes that “Our platform holds the potential to be adapted for…